News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘ImmuneSystem’ clear

  • Dana-Farber scientists have demonstrated a new strategy for treating autoimmune disease that successfully blocked the development of rheumatoid arthritis in a mouse model. They say it holds promise for improved treatment of arthritis and other autoimmune disorders in people.

Tags: BasicResearch, ImmuneSystem

  • A clinical trial for advanced melanoma caused growths to recede or stabilize in half of the participants by blocking a protein interaction that prevents T cells from attacking cancerous cells, reports lead author Stephen Hodi, MD.

Tags: ImmuneSystem, Melanoma

  • In a study that seems to pivot on a paradox, scientists at Dana-Farber Cancer Institute have used an immune system stimulant as an immune system suppressor to treat a common, often debilitating side effect of donor stem cell transplantation in cancer patients.

Tags: BasicResearch, GraftVersusHost, ImmuneSystem

  • A section of the AIDS virus's protein envelope known as the V3 loop and once considered an improbable target for a vaccine now appears to be one of the most promising, according to research authored by Dana-Farber's Ruth Ruprecht, MD, PhD.

Tags: BasicResearch, ImmuneSystem

  • Dana-Farber researchers have found that the basic cause of age-related health decline is malfunctioning telomeres — the end-caps on cells' chromosomes that protect them against DNA damage.

Tags: ImmuneSystem, Genetics

  • Dana-Farber researchers received the grant from the Defense Advanced Research Projects Agency and the Army Research Office to develop a treatment against known, unknown, naturally occurring, or engineered disease-causing pathogens.

Tags: Grants, ImmuneSystem

  • Dana-Farber Cancer Institute scientists identify cells in mice that prevent the immune system from attacking the animals' own cells, protecting them from autoimmune diseases.

Tags: ImmuneSystem

  • The use of monoclonal antibodies to activate an immune-system response to abnormal cells resulted in a significant increase in survival time in patients with metastatic melanoma, report Dana-Farber researchers.

Tags: ImmuneSystem, Melanoma, TranslationalResearch

  • The FDA's approval of Provenge®, a prostate cancer vaccine, marks a new era of using patients' immune systems to treat cancer.

Tags: ImmuneSystem, ProstateCancer, TranslationalResearch

  • Dana-Farber scientists have identified a protein that prevents the body's immune system from recognizing and attacking Hodgkin lymphoma cells. Based on this finding, the researchers are now investigating targeted therapies to disable this molecular "bodyguard" and boost a patient's ability to fight the blood cancer.

Tags: BasicResearch, ImmuneSystem, Lymphoma

Showing 1-10 of 12 items